Percentage of Participants Who Develop Skin Rash [clinicaltrials_resource:NCT00718315/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Percentage of Participants Who Develop Skin Rash [clinicaltrials_resource:NCT00718315/outcome/1]
Bio2RDF identifier
NCT00718315/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00718315/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
ITT Population
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Days 0, 15, and 30
type [clinicaltrials_vocabulary:type]
alternate
Percentage of Participants Who Develop Skin Rash
@en
identifier
clinicaltrials_resource:NCT00718315/outcome/1
title
Skin rash was assessed by the ...... amation” – short name “rash”).
@en
type
label
Percentage of Participants Who ...... esource:NCT00718315/outcome/1]
@en